“Comprehensive Toxicology and Pharmacogenomics Test Automation Within a Single LIMS Platform”
New Orleans (March 14, 2016) – For toxicology laboratories adding genomic analyses, UNIConnect, the specialist in laboratory process management software for molecular testing, will introduce their newest LIMS offering, pMDx-TOX, at the Society of Toxicology’s 55th Annual Meeting and ToxExpo, March 14-16.
Clinton Maddox, Vice President, Technical Operations, will highlight pMDx-TOX during the meeting session, “Software Considerations When Expanding Your Tox Lab to Include PGx,” on March 16, from 10:30 – 11:30 a.m., in Room 205, Ernest N. Morial Convention Center. Mr. Maddox’s presentation will discuss challenges encountered by Toxicology labs that are expanding their services to include molecular offerings such as pharmacogenomic testing. “Toxicology labs adding molecular testing for their customers are faced by specialized workflows that don’t fit into their LIMS systems – which means paper-based processes, extra time demands and the potential for error,” said Maddox. “pMDx-TOX is the first Toxicology-dedicated LIMS that integrates full-service pharmacogenomics test automation into the standard Tox workflow, with the same accessioning protocols, rigorous audit trails and robust reporting.”
Built upon UNIConnect’s best-in-class pMDx™ Precision Molecular Diagnostics LIMS platform, pMDX-TOX is tailored to the needs of the Toxicology laboratory environment. “Exacting accuracy, safety and patient privacy are our top concerns when developing laboratory automation systems,” said Bill Harten, UNIConnect founder and CEO. “We built pMDx™, around these principles, and they remain our standard as we customize to the needs of other lab types.” Harten cited the system’s support for regulatory and HIPAA compliance and added that the company prides itself on its service and rapid-response support during all phases of the customer experience. “We demonstrate on-the-fly system customization in a half-hour demo session, as an example of our system’s flexibility in the working laboratory setting. Also, our systems are built to scale automatically as the lab or business grows – from one site to many, and from hundreds to tens of thousands of samples per day. Laboratory size and specific needs pose no obstacle for our technology or our team.”
A summary of pMDx-TOX capabilities includes:
- Comprehensive out-of-the-box test and current medication menus that can be customized on the fly
- ICD-10 code selection
- Integration with analytical instrument software
- Parent drug and metabolite testing and reporting
- Automated reflex testing management, with billing support
- Specimen validity tracking, including pH, specific gravity and oxidant levels
- Tracking of samples sent for external analysis, with optional EMR integration
- Effortless scalability to respond to changes in test volume, from tens to hundreds to thousands of tests per day.
- Support for compliance requirements, including, HIPAA, CAP, CLIA, and more
Along with the informational session, Mr. Maddox and the UNIConnect Team will give individual pMDx-TOX demos and answer questions about all of UNIConnect’s Precision Molecular Diagnostic LIMS Suite offerings at Exhibitor Booth 1348. More information is available on the UNIConnect website, uniconnect.com.
# # #
Richard A. Mandahl, VP, Business Development, firstname.lastname@example.org, 801.243.5937 - direct
UNIConnect supports the science and business of precision medicine by delivering LIS/LIMS software solutions for molecular laboratories and the organizations they serve. The company provides process management software platforms that adapt to rapid change – whether through scientific, regulatory or reimbursement dynamics – and handle the precise tracking and process detail required for molecular diagnostics. UNIConnect systems enable laboratories to achieve their objectives, from the single lab to the global enterprise. www.uniconnect.com